Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMGN |
---|---|---|
09:32 ET | 35196 | 322.72 |
09:33 ET | 1022 | 322.47 |
09:35 ET | 2469 | 323.3 |
09:37 ET | 3970 | 322.005 |
09:39 ET | 3843 | 321.955 |
09:42 ET | 1004 | 322.05 |
09:44 ET | 1809 | 321.9 |
09:46 ET | 7384 | 321.69 |
09:48 ET | 6215 | 322.115 |
09:50 ET | 2001 | 322.6 |
09:51 ET | 500 | 322.84 |
09:53 ET | 1238 | 323.575 |
09:55 ET | 1084 | 323.21 |
09:57 ET | 1699 | 323.24 |
10:00 ET | 407 | 323.92 |
10:02 ET | 2196 | 323.865 |
10:04 ET | 4550 | 324.215 |
10:06 ET | 1700 | 324.03 |
10:08 ET | 4667 | 324.74 |
10:09 ET | 3331 | 325.06 |
10:11 ET | 2148 | 325.055 |
10:13 ET | 4416 | 325.345 |
10:15 ET | 1523 | 325.5117 |
10:18 ET | 2521 | 325.3538 |
10:20 ET | 1200 | 324.97 |
10:22 ET | 3347 | 324.685 |
10:24 ET | 2560 | 324.655 |
10:26 ET | 11351 | 324.84 |
10:27 ET | 5982 | 324.9225 |
10:29 ET | 2041 | 325.15 |
10:31 ET | 1514 | 325.34 |
10:33 ET | 1465 | 325.36 |
10:36 ET | 3623 | 325.35 |
10:38 ET | 2043 | 325.49 |
10:40 ET | 900 | 325.54 |
10:42 ET | 1222 | 325.6375 |
10:44 ET | 1656 | 325.82 |
10:45 ET | 1519 | 326.185 |
10:47 ET | 2893 | 326.405 |
10:49 ET | 3836 | 326.19 |
10:51 ET | 3555 | 326.14 |
10:54 ET | 1180 | 326.12 |
10:56 ET | 726 | 325.98 |
10:58 ET | 1594 | 325.87 |
11:00 ET | 2534 | 325.98 |
11:02 ET | 2197 | 325.86 |
11:03 ET | 1736 | 326.0375 |
11:05 ET | 4420 | 326.48 |
11:07 ET | 1532 | 326.44 |
11:09 ET | 12985 | 326.86 |
11:12 ET | 4704 | 327.05 |
11:14 ET | 1052 | 327.12 |
11:16 ET | 8333 | 326.9 |
11:18 ET | 1510 | 326.9 |
11:20 ET | 1208 | 327.39 |
11:21 ET | 8060 | 327.88 |
11:23 ET | 5562 | 327.81 |
11:25 ET | 1756 | 327.86 |
11:27 ET | 14042 | 327.7 |
11:30 ET | 300 | 327.725 |
11:32 ET | 1504 | 327.825 |
11:34 ET | 1151 | 327.71 |
11:36 ET | 3735 | 327.28 |
11:38 ET | 6686 | 326.7 |
11:39 ET | 2474 | 326.5 |
11:41 ET | 8089 | 326.01 |
11:43 ET | 7480 | 325.59 |
11:45 ET | 5500 | 325.365 |
11:48 ET | 19135 | 325.15 |
11:50 ET | 16679 | 326.665 |
11:52 ET | 989 | 326.72 |
11:54 ET | 2154 | 326.335 |
11:56 ET | 1653 | 326.5499 |
11:57 ET | 326 | 326.185 |
11:59 ET | 2560 | 326.03 |
12:01 ET | 600 | 326.005 |
12:03 ET | 1044 | 325.9056 |
12:06 ET | 2000 | 326.23 |
12:08 ET | 979 | 326.025 |
12:10 ET | 298 | 326.0734 |
12:12 ET | 500 | 326.16 |
12:14 ET | 2032 | 326.05 |
12:15 ET | 321 | 326.025 |
12:17 ET | 2424 | 326.22 |
12:19 ET | 401 | 326.76 |
12:21 ET | 16278 | 326.09 |
12:24 ET | 1501 | 325.97 |
12:26 ET | 968 | 326.23 |
12:28 ET | 8936 | 326.36 |
12:30 ET | 10394 | 326.755 |
12:32 ET | 4420 | 326.32 |
12:33 ET | 2486 | 326.23 |
12:35 ET | 300 | 326.235 |
12:37 ET | 400 | 326.36 |
12:39 ET | 596 | 326.38 |
12:42 ET | 4045 | 326 |
12:44 ET | 2020 | 326.08 |
12:46 ET | 722 | 326.105 |
12:48 ET | 2228 | 326.03 |
12:50 ET | 100 | 326.015 |
12:51 ET | 5218 | 326.2 |
12:53 ET | 3407 | 326.34 |
12:55 ET | 1800 | 326.24 |
12:57 ET | 2493 | 326.03 |
01:00 ET | 2301 | 326.16 |
01:02 ET | 1905 | 326.2 |
01:04 ET | 1339 | 326.2 |
01:06 ET | 4842 | 326 |
01:08 ET | 1400 | 326.03 |
01:09 ET | 1125 | 326.14 |
01:11 ET | 691 | 326.035 |
01:13 ET | 700 | 326.23 |
01:15 ET | 1326 | 326.515 |
01:18 ET | 876 | 326.61 |
01:20 ET | 743 | 326.68 |
01:22 ET | 1042 | 326.2625 |
01:24 ET | 500 | 326.265 |
01:26 ET | 1963 | 326.59 |
01:27 ET | 7813 | 326.46 |
01:29 ET | 1651 | 326.24 |
01:31 ET | 1570 | 326.1 |
01:33 ET | 300 | 326.23 |
01:36 ET | 2328 | 326.37 |
01:38 ET | 7120 | 326.05 |
01:40 ET | 300 | 325.995 |
01:42 ET | 1476 | 325.8937 |
01:44 ET | 1788 | 325.72 |
01:45 ET | 4824 | 325.955 |
01:47 ET | 6230 | 326.085 |
01:49 ET | 2178 | 325.965 |
01:51 ET | 1625 | 325.805 |
01:54 ET | 606 | 325.7 |
01:56 ET | 1786 | 325.78 |
01:58 ET | 200 | 325.69 |
02:00 ET | 1973 | 325.59 |
02:02 ET | 1462 | 325.669 |
02:03 ET | 1132 | 325.95 |
02:05 ET | 400 | 326.01 |
02:07 ET | 4378 | 325.85 |
02:09 ET | 3602 | 326.085 |
02:12 ET | 3813 | 326.1167 |
02:14 ET | 1262 | 326.085 |
02:16 ET | 2336 | 326.22 |
02:18 ET | 4383 | 326.51 |
02:20 ET | 1476 | 326.84 |
02:21 ET | 1386 | 326.66 |
02:23 ET | 2918 | 326.815 |
02:25 ET | 417 | 326.8449 |
02:27 ET | 801 | 326.7218 |
02:30 ET | 3584 | 327.02 |
02:32 ET | 1858 | 327.285 |
02:34 ET | 1300 | 327.41 |
02:36 ET | 700 | 327.5 |
02:38 ET | 7210 | 327.325 |
02:39 ET | 8737 | 326.8768 |
02:41 ET | 700 | 327.08 |
02:43 ET | 2004 | 327.16 |
02:45 ET | 2176 | 327.68 |
02:48 ET | 1544 | 327.47 |
02:50 ET | 603 | 327.465 |
02:52 ET | 1582 | 327.3812 |
02:54 ET | 761 | 327.29 |
02:56 ET | 1235 | 327.24 |
02:57 ET | 300 | 327.36 |
02:59 ET | 633 | 327.265 |
03:01 ET | 2428 | 326.73 |
03:03 ET | 1234 | 326.74 |
03:06 ET | 1588 | 326.6201 |
03:08 ET | 2832 | 326.795 |
03:10 ET | 1508 | 326.515 |
03:12 ET | 2172 | 326.47 |
03:14 ET | 1309 | 326.29 |
03:15 ET | 2229 | 326.1875 |
03:17 ET | 6040 | 326.1325 |
03:19 ET | 2456 | 325.875 |
03:21 ET | 1606 | 325.895 |
03:24 ET | 4620 | 325.72 |
03:26 ET | 5272 | 325.58 |
03:28 ET | 10288 | 325.715 |
03:30 ET | 5604 | 325.4 |
03:32 ET | 750 | 325.51 |
03:33 ET | 3427 | 325.45 |
03:35 ET | 1817 | 325.36 |
03:37 ET | 1398 | 325.35 |
03:39 ET | 998 | 325.5272 |
03:42 ET | 2549 | 325.37 |
03:44 ET | 11558 | 325.44 |
03:46 ET | 2980 | 325.13 |
03:48 ET | 3582 | 325.259 |
03:50 ET | 1735 | 325.24 |
03:51 ET | 2901 | 325.29 |
03:53 ET | 2919 | 325.525 |
03:55 ET | 8320 | 325.471 |
03:57 ET | 19397 | 325.26 |
04:00 ET | 616888 | 325.28 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amgen Inc | 174.8B | 41.6x | -0.22% |
Gilead Sciences Inc | 120.3B | 1,149.7x | +1.53% |
AstraZeneca PLC | 199.4B | 31.3x | +17.52% |
Bristol-Myers Squibb Co | 109.8B | -15.1x | +4.90% |
Novartis AG | 233.1B | 18.5x | -5.59% |
Haleon PLC | 42.7B | 17.7x | --- |
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $174.8B |
---|---|
Revenue (TTM) | $32.5B |
Shares Outstanding | 537.5M |
Dividend Yield | 2.77% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 11-18-24 |
Pay Date | 12-09-24 |
Beta | 0.58 |
EPS | $7.82 |
Book Value | $11.64 |
P/E Ratio | 41.6x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | 17.8x |
Operating Margin | 19.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.